Subclinical cardiac dysfunction after hypertensive disorders in pregnancy

妊娠期高血压疾病后的亚临床心功能不全

基本信息

  • 批准号:
    10002116
  • 负责人:
  • 金额:
    $ 14.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-06 至 2023-04-30
  • 项目状态:
    已结题

项目摘要

7. ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality globally. About three quarters of CVD deaths occur in the low- and middle-income settings. Although CVD related deaths have progressively declined in high income settings, mortality among adults below 55 years especially women have stagnated, most likely due to female specific risk factors. One such factor, new onset hypertensive disorders of pregnancy (HDP) is associated with 2-fold or greater risk for future metabolic syndrome, chronic low-grade inflammation and heart failure. However, majority of studies on long-term heart failure risk after HDP have mostly focused on end-stage disease and not the progression of asymptomatic cardiac dysfunction. Previous studies have shown that even the asymptomatic patients with myocardial dysfunction have compromised prognosis with an increased risk of developing symptomatic heart failure in the future. Therefore, early identification of at-risk population of women is critical and would allow implementation of intervention strategies to delay the progression or to prevent the onset of heart failure. Few studies in high income settings and none in SSA have evaluated the risk and correlates of subclinical cardiac dysfunction after HDP using speckle tracking echocardiography (STE) which accurately quantifies myocardial mechanics, including global longitudinal strain (GLS), a prognostic marker of adverse CVD outcomes. Using STE, we aim to understand and describe the presence and progression of asymptomatic cardiac dysfunction after pregnancies complicated with HDP (Aim 1) and evaluate the contribution of inflammation at 3 years postpartum by comparing women with and without new onset of new hypertensive disorders of pregnancy (Aims 2 and 3). The study findings will inform the development of novel and scalable screening and monitoring strategies to manage CVD risk after HDP and therefore reduce CVD and CVD- mortality in sub-Saharan Africa and globally.
7.摘要 心血管疾病(CVD)仍然是全球死亡的主要原因。大约四分之三的CVD 死亡发生在低收入和中等收入环境中。尽管CVD相关死亡率逐渐下降, 在高收入环境中,55岁以下成年人特别是妇女的死亡率很可能停滞不前, 女性特有的风险因素。其中一个因素,新发妊娠高血压疾病(HDP), 与未来代谢综合征、慢性低度炎症和心脏病的2倍或更高风险相关 失败然而,大多数关于HDP后长期心力衰竭风险的研究大多集中在终末期, 疾病而不是无症状心功能不全的进展。此前的研究表明,即使 无症状的心肌功能障碍患者预后较差, 将来会出现症状性心力衰竭因此,及早识别高危人群的妇女 是至关重要的,并将允许实施干预策略,以延迟进展或防止 心力衰竭发作。在高收入环境中的研究很少,在SSA中没有一项研究评估了风险, 使用斑点追踪超声心动图(STE)研究HDP后亚临床心功能不全的相关性, 准确量化心肌力学,包括整体纵向应变(GLS),一个预后指标, 心血管疾病的不良后果。使用STE,我们的目标是了解和描述的存在和进展, 妊娠合并HDP后无症状心功能不全(目的1),并评估其贡献 通过比较有和没有新发高血压的妇女, 妊娠障碍(目标2和3)。研究结果将为开发新颖且可扩展的 筛查和监测策略,以管理HDP后的CVD风险,从而减少CVD和CVD- 撒哈拉以南非洲和全球的死亡率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CAREY FARQUHAR其他文献

CAREY FARQUHAR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CAREY FARQUHAR', 18)}}的其他基金

Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention
整合辅助合作伙伴服务和系统发育学以预防 HIV 和 HCV
  • 批准号:
    10208545
  • 财政年份:
    2017
  • 资助金额:
    $ 14.06万
  • 项目类别:
IMPLEMENTING ASSISTED PARTNER SERVICES TO HIV TEST AND TREAT MEN IN WESTERN KENYA
为肯尼亚西部的男性实施艾滋病毒检测和治疗的辅助合作伙伴服务
  • 批准号:
    9797235
  • 财政年份:
    2017
  • 资助金额:
    $ 14.06万
  • 项目类别:
Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention
整合辅助合作伙伴服务和系统发育学以预防 HIV 和 HCV
  • 批准号:
    10086117
  • 财政年份:
    2017
  • 资助金额:
    $ 14.06万
  • 项目类别:
Implementing Assisted Partner Services to HIV Test and Treat Men in Western Kenya
在肯尼亚西部实施艾滋病毒检测和治疗男性辅助合作伙伴服务
  • 批准号:
    9407079
  • 财政年份:
    2017
  • 资助金额:
    $ 14.06万
  • 项目类别:
Implementing Assisted Partner Services to HIV Test and Treat Men in Western Kenya
在肯尼亚西部实施艾滋病毒检测和治疗男性辅助合作伙伴服务
  • 批准号:
    10155081
  • 财政年份:
    2017
  • 资助金额:
    $ 14.06万
  • 项目类别:
Predicting Early Cardiovascular Risk among HIV-Infected and Uninfected Kenyan Adults
预测感染艾滋病毒和未感染艾滋病毒的肯尼亚成年人的早期心血管风险
  • 批准号:
    9354370
  • 财政年份:
    2016
  • 资助金额:
    $ 14.06万
  • 项目类别:
Predicting Early Cardiovascular Risk among HIV-Infected and Uninfected Kenyan Adults
预测感染艾滋病毒和未感染艾滋病毒的肯尼亚成年人的早期心血管风险
  • 批准号:
    9231919
  • 财政年份:
    2016
  • 资助金额:
    $ 14.06万
  • 项目类别:
Women and HIV: Translation of Research into Practice
妇女与艾滋病毒:研究转化为实践
  • 批准号:
    9283645
  • 财政年份:
    2015
  • 资助金额:
    $ 14.06万
  • 项目类别:
Women and HIV: Translation of Research into Practice
妇女与艾滋病毒:研究转化为实践
  • 批准号:
    9488546
  • 财政年份:
    2015
  • 资助金额:
    $ 14.06万
  • 项目类别:
Improving the HIV Care Cascade in Kenya through Implementation Science Training
通过实施科学培训改善肯尼亚的艾滋病毒护理梯级
  • 批准号:
    10462025
  • 财政年份:
    2013
  • 资助金额:
    $ 14.06万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.06万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 14.06万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 14.06万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 14.06万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 14.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 14.06万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 14.06万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 14.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 14.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 14.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了